CervoMed Inc.: regulation FD disclosure and exhibit filed

What happened
CervoMed Inc. filed a Form 8-K on Oct 14, 2026 stating that "certain information concerning the business, clinical studies, development plans, financial position, and related matters" is being made available on its website, www.cervomed.com, under the heading "Investors – Events and Presentations." The filing says representatives of the company may use the presentation, "in whole or in part, and possibly with non-material modifications," in conferences, meetings and presentations to investors, analysts and others. The filing also states the information is summary information to be considered in the context of the company’s SEC filings and other public announcements and that the company "undertakes no duty or obligation to publicly update or revise the information" except as required by law.

Key details

• Form 8-K filed on Oct 14, 2026 reporting Item 7.01 (Regulation FD disclosure) and Item 9.01 (financial statements and exhibits).
• The presentation is posted at www.cervomed.com under "Investors – Events and Presentations."
• The filing notes company representatives may use the presentation "in whole or in part" and that any updating may be made through SEC filings, press releases, or other public disclosure.
• The filing includes an Inline XBRL cover page interactive data file as an exhibit.

Why it may matter
Item 7.01 reports a Regulation FD disclosure, which covers the posting and use of a presentation about the company's business and clinical and development matters. Item 9.01 reports exhibits filed with the Form 8-K, including the interactive cover page data. A filing does not show why the insider traded or why the company acted.